Hemendra N. Bhargava
#136,972
Most Influential Person Now
Hemendra N. Bhargava's AcademicInfluence.com Rankings
Download Badge
Chemistry
Hemendra N. Bhargava's Degrees
- PhD Chemistry University of California, Berkeley
Why Is Hemendra N. Bhargava Influential?
(Suggest an Edit or Addition)Hemendra N. Bhargava's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Triclosan: applications and safety. (1996) (490)
- Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. (1994) (193)
- Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice. (1979) (98)
- Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats. (1990) (94)
- Evidence for a bidirectional cross-tolerance between morphine and delta 9-tetrahydrocannabinol in mice. (1994) (89)
- Cyclo (leucylglycine) inhibits the development of morphine induced analgesic tolerance and dopamine receptor supersensitivity in rats. (1980) (83)
- Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord. (1989) (82)
- Effects of morphine tolerance and abstinence on cellular immune function (1994) (82)
- Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice. (1972) (77)
- Comparison of immune functional parameters following in vitro exposure to natural and synthetic amphetamines. (1994) (71)
- Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat. (1995) (68)
- The effects of thyrotropin releasing hormone and histidyl-proline diketopiperazine on delta-9-tetrahydrocannabinol-induced hypothermia. (1980) (67)
- Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. (1995) (64)
- Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol. (1976) (64)
- Immunomodulatory effects of in vitro exposure to morphine and its metabolites. (1995) (64)
- Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat. (1993) (60)
- On the presence of serotonin in the gut lumen and possible release mechanisms. (1981) (59)
- The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1–13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat (1992) (57)
- β-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats (1991) (56)
- Quantitation of morphine tolerance induced by pellet implantation in the rat (1978) (55)
- Influence of thyrotropin releasing hormone and histidyl-proline diketopiperazine on spontaneous locomotor activity and analgesia induced by delta 9-tetrahydrocannabinol in the mouse. (1980) (52)
- Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy). (1995) (52)
- Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats. (1990) (52)
- Comparative effects of N G-monomethyl-d-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice (1994) (52)
- Effects of methionine-enkephalin and morphine on spontaneous locomotor activity: Antagonism by naloxone (1978) (52)
- Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats. (1988) (51)
- Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice (1976) (50)
- Development of narcotic tolerance and physical dependence: Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) (1980) (50)
- Nitric oxide synthase activity in brain regions and spinal cord of mice and rats: kinetic analysis. (1995) (49)
- Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat. (1981) (45)
- A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides (1996) (44)
- The effect of 6-hydroxydopamine on morphine tolerance and physical dependence. (1972) (43)
- Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone. (1995) (42)
- Multiple opiate receptors of brain and spinal cord in opiate addiction. (1991) (42)
- Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study (1995) (42)
- Blockage of narcotic-induced dopamine receptor supersensitivity by cyclo(Leu-Gly). (1979) (41)
- Interactions of thyrotropin releasing hormone, its metabolites and analogues with endogenous and exogenous opiates. (1983) (41)
- Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats (1984) (41)
- Antagonism of ketamine-induced anesthesia and hypothermia by thyrotropin releasing hormone and cyclo(His-Pro) (1981) (40)
- Selective proliferation of brain kappa opiate receptors in spontaneously hypertensive rats. (1986) (40)
- Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a κ-opioid receptor agonist, in the mouse (1994) (39)
- Cerebral cortical 5-HT1, and 5-HT2, receptors of morphine tolerant-dependent rats (1988) (39)
- Dissociation of tolerance to the analgesic and hypothermic effects of morphine by using thyrotropin releasing hormone (1981) (39)
- The effects of naltrexone on the development of physical dependence on morphine. (1978) (39)
- Inhibition by Z-Pro-D-Leu of development of tolerance to and physical dependence on morphine in mice. (1978) (39)
- Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine. (1995) (39)
- Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine. (1997) (38)
- Evidence for the role of nitric oxide in κ-opiate tolerance in mice (1993) (38)
- Potential therapeutic applications of naturally occurring and synthetic cannabinoids. (1978) (38)
- Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone (1986) (37)
- Opioid peptides in pituitary gland, brain regions and peripheral tissues of spontaneously hypertensive and Wistar-Kyoto normotensive rats (1988) (37)
- Suppression of immune function by non-peptidic delta opioid receptor antagonists (1995) (37)
- Down-regulation of hypothalamic 5-HT1A receptors in morphine-abstinent rats. (1990) (37)
- THE EFFECT OF MELANOTROPHIN RELEASE INHIBITING FACTOR (MIF) AND CYCLO (LEU‐GLY) ON THE TOLERANCE TO MORPHINE‐INDUCED ANTINOCICEPTION IN THE RAT: A DOSE‐RESPONSE STUDY (1981) (37)
- Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats. (1989) (36)
- Antagonism of the acute pharmacological actions of morphine by panax ginseng extract. (1990) (36)
- Effects of morphine in rats treated chronically with U-50,488 H, a κ opioid receptor agonist (1989) (35)
- Effect of cyclic nucleotides and phosphodiesterase inhibition on morphine tolerance and physical dependence. (1975) (35)
- Absolute configuration of the enantiomers of 7-chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline (chloroquine) (1988) (34)
- The effect of Panax ginseng on the development of tolerance to the pharmacological actions of morphine in the rat. (1991) (34)
- Sensitization to the locomotor stimulant activity of cocaine is associated with increases in nitric oxide synthase activity in brain regions and spinal cord of mice. (1997) (34)
- In vitro evaluation of fentanyl and meperidine for immunomodulatory activity. (1995) (33)
- The effects of peptides on tolerance to the cataleptic and hypothermic effects of morphine in the rat (1981) (32)
- Effect of nitric oxide synthase inhibition on tolerance to the analgesic action of D-Pen2, D-Pen5 enkephalin and morphine in the mouse (1996) (32)
- Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of Δ9-tetrahydrocannabinol in mice (1994) (32)
- Effect of antagonism of the NMDA receptor on tolerance to [d-Pen2,d-Pen5]enkephalin, a δ 1-Opioid receptor agonist (1996) (31)
- Kappa opioid receptor activity in spontaneously hypertensive rats. (1988) (31)
- Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine Influence of pro-Leu-Gly-NH2 and cyclo(Leu-Gly) (1983) (31)
- Effect of morphine tolerance and abstinence on the binding of [3H]MK-801 to brain regions and spinal cord of the rat (1994) (31)
- Inhibition of abstinence syndrome in opiate dependent mice by cyclo (His-Pro). (1981) (30)
- Effects of N-methyl-d-aspartate receptor antagonists on the analgesia and tolerance to d-Ala2,Glu4 deltorphin II, a δ2-opioid receptor agonist in mice (1996) (30)
- Effect of chemical sympathectomy on morphine antinociception and tolerance development in the rat. (1973) (30)
- Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. (1996) (30)
- Binding of [3H][D-Ala2, MePhe4, Gly-ol5] Enkephalin, [3H][D-Pen2, D-Pen5]Enkephalin, and [3H]U-69,593 to Airway and Pulmonary Tissues of Normal and Sensitized Rats (1997) (30)
- Time course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse: reversal by naltrexone. (1997) (30)
- Brain acetylcholine and choline following acute and chronic morphine treatment and during withdrawal. (1975) (29)
- Effect of 7-Nitroindazole on Tolerance to Morphine, U-50,488H and [d-Pen2, d-Pen5]Enkephalin in Mice (1997) (29)
- Intragastric administration of cyclo(Leu-Gly) inhibits the development of tolerance to the analgesic effect of morphine in the rat. (1988) (29)
- Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [d-Ala2,Glu4]deltorphin II, a δ 2-Opioid receptor agonist in mice (1996) (29)
- Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY 235959, a competitive antagonist of the NMDA receptor. (1997) (29)
- Inhibition of neuroleptic-induced dopamine receptor supersensitivity by cyclo (Leu-Gly) (1980) (28)
- Brain serotonin turnover and morphine tolerance-dependence induced by multiple injections in the rat. (1977) (27)
- Immunological consequences of in vitro exposure to lysergic acid diethylamide (LSD). (1994) (27)
- Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat. (1994) (27)
- Analgesic and hyperthermic effects of intravenously administered morphine in the rat are related to its serum levels. (1991) (26)
- The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites. (1983) (25)
- The vagal release of 5-hydroxytryptamine from enterochromaffin cells in the cat. (1978) (25)
- Influence of hemicholinium (HC-3) on morphine analgesia, tolerance, physical dependence and on brain acetylcholine. (1974) (24)
- Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome (1978) (24)
- Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists. (1976) (23)
- Effects of Acute Administration of l-Arginine on Morphine Antinociception and Morphine Distribution in Central and Peripheral Tissues of Mice (1998) (23)
- Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats (1993) (23)
- Effect of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate (1994) (22)
- Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat. (1995) (22)
- Effect of 1-phenyl-3-(2-thiazolyl)-2-thiourea, a dopamine beta-hydroxylase inhibitor on morphine analgesia, tolerance and physical dependence. (1974) (22)
- Cardiovascular responses to κ opioid agonists in intact and adrenal demedullated rats (1988) (22)
- The effects of a hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat. (1981) (22)
- Effects of competitive and noncompetitive antagonists of the N‐methyl‐D‐aspartate receptor on the analgesic action of δ1‐ and δ2‐opioid receptor agonists in mice (1996) (21)
- The effect of cyclo (Leu-Gly) on chemical denervation supersensitivity of dopamine receptors induced by intracerebroventricular injection of 6-hydroxydopamine in mice. (1980) (21)
- Effects of morphine tolerance-dependence and abstinence on kappa-opiate receptors of rat brain and spinal cord. (1991) (20)
- Evidence for a role of N-Methyl-d-aspartate receptors in l-arginine-induced attenuation of morphine antinociception (1998) (20)
- Enhanced response to apomorphine in rats treated with multiple injections of human beta endorphin and its blockade by Pro-Leu-Gly-NH2 and cyclo (Leu-Gly). (1981) (20)
- Improved recovery of morphine from biological tissues using siliconized glassware. (1977) (20)
- Opiate-like action of methionine-enkephalin in inhibiting morphine abstinence syndrome. (1977) (20)
- Pharmacodynamics and pharmacokinetics of intravenously administered morphine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. (1992) (19)
- Structure activity relationship studies with hypothalamic peptide hormones. II. Effects of thyrotropin releasing hormone analogs on morphine-induced responses in mice. (1982) (19)
- Effect of cyclo(leucyl-glycine) on [3H]spiroperidol binding in the corpus striatum and hypothalamus of spontaneously hypertensive rats. (1984) (19)
- The Effect of PTH Antagonist BIM-44002 on Serum Calcium and PTH Levels in Hypercalcemic Hyperparathyroid Patients (1997) (19)
- Differences in the binding of [3H][D-Ser2,Thr6]leucine-enkephalin and [3H][D-Pen2,D-Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats. (1991) (18)
- The effect of propranolol on the serotonin concentration in the portal plasma after vagal nerve stimulation in the cat. (1979) (18)
- Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase. (1984) (18)
- Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats (1987) (18)
- Spontaneously hypertensive rats exhibit supersensitivity to the hypertensive and hyperthermic effects of thyrotropin releasing hormone (1987) (18)
- Effects of multiple intracerebroventricular injections of [d-Pen2,d-Pen5]enkephalin and [d-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain δ-opioid receptors (1997) (17)
- Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat. (1995) (17)
- Multiple opiate receptors and pharmacological response to morphine in rats maintained on diets differing in protein concentration. (1987) (17)
- Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice (1996) (17)
- Effects of ibogaine on the development of tolerance to antinociceptive action of μ-, δ- and κ-opioid receptor agonists in mice (1997) (17)
- Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain μ, δ and κ opiate receptors (1983) (17)
- Rapid induction and quantitation of morphine dependence in the rat by pellet implantation (1977) (16)
- Biochemical and behavioral studies on the interaction between μ- and κ-opiate agonists in mice (1993) (16)
- Mechanism of toxicity and rationale for use of the combination of pentazocine and pyribenzamine in morphine-dependent subjects. (1981) (16)
- Effects of ibogaine and noribogaine on the antinociceptive action of μ-, δ- and κ-opioid receptor agonists in mice (1997) (16)
- The effect of thyrotropin releasing hormone and morphine on gastrointestinal transit (1984) (16)
- Time course of the distribution of morphine in brain regions, spinal cord and serum following intravenous injection to rats of differing ages. (1993) (16)
- Effect of peptides on the development of tolerance to buprenorphine, a mixed opiate agonist-antagonist analgesic. (1982) (16)
- Tolerance-dependence and serum elimination of morphine in rats implanted with morphine pellets. (1991) (15)
- Effect of repeated administration of manganese on the striatal cholinergic and dopaminergic receptors in the rat. (1987) (15)
- Characteristics of central binding sites for [3H] DAMGO in spontaneously hypertensive rats. (1990) (15)
- Effects of naltrexone on the binding of [3H]D-Ala2, MePhe4, Gly-ol5-enkephalin to brain regions and spinal cord and pharmacological responses to morphine in the rat. (1993) (15)
- Modulation of preproenkephalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine (1995) (15)
- Effect of repeated administration of U-50,488H, a kappa opioid receptor agonist, on central 5-HT1 and 5-HT2 receptors in the rat. (1989) (15)
- Down-regulation of central μ and δ opiate receptors in morphine tolerant-dependent rats (1990) (15)
- Evidence for the involvement of central opioidergic systems in L-tyrosine methyl ester-induced analgesia in the rat. (1988) (15)
- The role of metabolism in the action of prolyl-leucyl-glycinamide on the development of tolerance to the analgesic effect of morphine (1986) (14)
- Differential effects of LY235959, a competitive antagonist of the NMDA receptor on κ-opioid receptor agonist induced responses in mice and rats (1997) (14)
- Sensitization to the locomotor stimulant effect of cocaine modifies the binding of [3H]MK-801 to brain regions and spinal cord of the mouse. (1999) (14)
- Kinetic Properties of Nitric Oxide Synthase in Cerebral Cortex and Cerebellum of Morphine Tolerant Mice (1998) (14)
- NG-nitro-L-arginine reverses L-arginine induced changes in morphine antinociception and distribution of morphine in brain regions and spinal cord of the mouse (1997) (14)
- Time course of the distribution of morphine in brain regions and spinal cord after intravenous injection to spontaneously hypertensive and normotensive Wistar-Kyoto rats. (1992) (14)
- Effects of kappa-opioid receptor agonists and morphine on food intake and urinary output in food-deprived and nondeprived rats (1989) (14)
- Effect of Chronic Administration of Morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the Concentration of cGMP in Brain Regions and Spinal Cord of the Mouse (1997) (13)
- Effect of cyclo(Leu-Gly) on the supersensitivity of dopamine receptors in spontaneously hypertensive rats. (1983) (13)
- Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol. (1996) (13)
- The effect of U-50,488H, a kappa-opiate receptor agonist on tolerance to the analgesic and hyperthermic effects of morphine in the rat. (1991) (13)
- Effects of naltrexone on pharmacodynamics and pharmacokinetics of intravenously administered morphine in the rat. (1993) (13)
- Pharmacological responses to acute morphine administration in normotensive Wistar-Kyoto and spontaneously hypertensive rats. (1982) (13)
- Differential binding of [3H]MK-801 to brain regions and spinal cord of mice treated chronically with morphine. (1996) (13)
- Studies on the possible role of pharmacokinetics in the development of tolerance to morphine in the rat. (1992) (12)
- Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat. (1982) (12)
- Stereospecific opiate receptors in the actions of thyrotropin releasing hormone and morphine on gastrointestinal transit. (1985) (12)
- Effect of varying concentration of ethanol on systemic hemodynamics and regional circulation. (1989) (12)
- Comparison of the hallucinogenic indole alkaloids ibogaine and harmaline for potential immunomodulatory activity. (1995) (12)
- Enhancement of Morphine Antinociception by Ibogaine and Noribogaine in Morphine-Tolerant Mice (1998) (12)
- Effect of prolyl-leucyl-glycinamide on blood pressure, heart rate and angiotensin converting enzyme activity in spontaneously hypertensive and Wistar-Kyoto normotensive rats. (1985) (12)
- Unidirectional interaction between thyrotropin releasing hormone and opiates at the level of their brain receptors. (1987) (12)
- Effect of methimazole-induced hypothyroidism on multiple opioid receptors in rat brain regions. (1988) (12)
- Methionine-enkephalin and beta-endorphin levels in spleen and thymus gland of morphine tolerant-dependent and abstinent rats. (1989) (11)
- Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of δ1- and δ2-opioid receptor agonists (1996) (11)
- Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats. (1991) (11)
- New in vivo evidence for narcotic agonistic property of leucine-enkephalin. (1978) (11)
- Opioid peptides, receptors, and immune function. (1990) (11)
- Analgesic and thermic responses to intravenously administered morphine in 8- and 24-week-old rats. (1991) (11)
- Stereospecific effects of a kappa-opiate antagonist on the actions of morphine in morphine-tolerant rats. (1989) (11)
- Effect of multiple injections of U-50, 488H, a kappa-opioid receptor agonist, on the activity of nitric oxide synthase in brain regions and spinal cord of mice. (1997) (11)
- Distribution of morphine in brain regions, spinal cord and serum following intravenous injection to morphine tolerant rats (1992) (11)
- Pharmacodynamics and kinetics of loss of tolerance and physical dependence on morphine induced by pellet implantation in the rat. (1992) (11)
- Evidence for a peripheral action of thyrotropin releasing hormone on gastrointestinal transit in mice (1988) (11)
- Effects of naltrexone pellet implantation on morphine tolerance and physical dependence in the rat. (1994) (11)
- Synthesis and opiate receptor binding properties of 17-methyl-6,7-dehydro-3,14-dihydroxy-4,5alpha-epoxy-6,7:4',5'-pyrimidin omorphinans. (1999) (11)
- Molecular modification of anticholinergics as probes for muscarinic receptors. 3. Conformationally restricted analogues of benactyzine. (1987) (11)
- Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide (1987) (11)
- Effect of ethanol on the binding of conformationally rigid and labile ligands of opioid receptors to rat brain membranes. (1988) (10)
- Comparative effects of synthetic enkephalinamides and morphine on abstinence responses in morphine-dependent mice (1980) (10)
- Naltrexone-induced alterations of the distribution of morphine in brain regions and spinal cord of the rat (1993) (10)
- Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages (1994) (10)
- The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats (1989) (10)
- Effect of lithium treatment on blood pressure and angiotensin-converting enzyme activity in normotensive Wistar-Kyoto and spontaneously hypertensive rats. (1985) (9)
- Immunotoxicology of opioids, inhalants, and other drugs of abuse. (1997) (9)
- Effects of naltrexone on morphine-induced tolerance and physical dependence and changes in cellular immune function in mice (1995) (9)
- Inability of cyclo (LEU-GLY) to facilitate the development of tolerance to and physical dependence on morphine in the rat. (1980) (9)
- Adaptive cholinergic-dopaminergic responses in morphine dependence. (1975) (9)
- Studies on the mechanism of thyrotropin releasing hormone induced inhibition of gastrointestinal transit (1985) (9)
- Effects of noribogaine on the development of tolerance to antinociceptive action of morphine in mice (1997) (9)
- The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1–13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat (1993) (8)
- Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat. (1994) (8)
- Brain and pituitary receptors for thyrotropin-releasing hormone in hypothyroid rats. (1989) (8)
- Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a κ-opioid receptor agonist (1997) (8)
- In vitro exposure to peptidic delta opioid receptor antagonists results in limited immunosuppression (1997) (7)
- Effect of chronic administration of L-arginine, NG-nitro-L-arginine or their combination on morphine concentration in peripheral tissues and urine of the mouse. (1998) (7)
- Changes in multiple opioid receptors in regions of the brain in rats treated chronically with thyroxine (1989) (7)
- Synthesis and stereochemical assignment of 7‐arylidene and 7‐heteroarylidene morphinan‐6‐ones (1996) (7)
- Effect of chronic treatment with morphine on the binding of 3H-N-n-propylnorapomorphine to striatal membranes of rats: influence of prolyl-leucyl-glycinamide. (1985) (7)
- Studies of the Possible Role of Brain Endorphins in Pentobarbital Anesthesia and Toxicity in Mice (1979) (7)
- beta-Endorphin-like immunoreactivity in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and -abstinent rats. (1994) (6)
- Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice. (1997) (6)
- Determination of ring phosphates in sodium phosphate glass (1967) (6)
- Effect of Chronic Administration of [D-Pen2, D-Pen5]Enkephalin on the Activity of Nitric Oxide Synthase in Brain Regions and Spinal Cord of Mice (1998) (6)
- MODIFICATION OF DEVELOPMENT OF PHYSICAL DEPENDENCE ON MORPHINE BY THYROTROPIN-RELEASING HORMONE (1980) (6)
- Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat. (1993) (6)
- Analgesic and Thermic Effects, and Cerebrospinal Fluid and Plasma Pharmacokinetics, of Intracerebroventricularly Administered Morphine in Normal and Sensitized Rats (1998) (6)
- Effects of acute and chronic administration of L-arginine on the antinociceptive action of morphine-6-beta-D-glucuronide. (1997) (6)
- Comparative effects of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly) administered orally on the development of tolerance to the analgesic effect of morphine in the rat (1989) (6)
- Effects of ibogaine and noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice. (1997) (6)
- Modification of the characteristics of dopamine transporter in brain regions and spinal cord of morphine tolerant and abstinent rats (1996) (6)
- Phencyclidine exposure alters in vitro cellular immune response parameters associated with host defense. (1993) (6)
- Synthesis of 2′‐amino‐17‐cyclopropylmethyl‐6,7‐dehydro‐3,14‐dihydroxy‐4,5α‐epoxy‐6,7:4′,5′‐thiazolomorphinan from naltrexone (1997) (5)
- Drugs that modify opioid tolerance, physical dependence, and abstinence symptoms: preclinical and clinical studies. (1995) (5)
- The effects of stereoisomers of 2- and 9- aminobenzonorbornenes on food intake, brain serotonin concentration and monoamine oxidase activity in the rat. (1982) (5)
- Effects of NMDA receptor antagonists on δ1- and δ2-opioid receptor agonists-induced changes in the mouse brain []DPDPE binding (1997) (5)
- Cardiovascular responses to kappa opioid agonists in intact and adrenal demedullated rats. (1988) (5)
- The binding of 3H-(3-MeHis2)thyrotropin releasing hormone to brain membranes and temperature response to thyrotropin releasing hormone in different strains of mice (1986) (5)
- The effects of thyrotropin-releasing hormone on the central nervous system responses to chronic morphine administration (2004) (5)
- Hypothalamic peptide hormone, prolyl-leucyl-glycinamide and analog, inhibit tolerance to the analgesic and locomotor depressant but not to the locomotor stimulant effects of morphine in the mouse (1982) (5)
- Effect of thyrotropin releasing hormone on the development of tolerance to the analgesic and hyperthermic actions of morphine in the rat (1990) (5)
- Methionine-enkephalin concentrations in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of U-50,488H-tolerant and abstinent rats. (1994) (5)
- Binding of 3H-D-Pen2-D-Pen5-enkephalin to brain regions and spinal cord membranes of spontaneously hypertensive and normotensive Wistar-Kyoto rats. (1993) (5)
- Chronic blockade of opioid receptors alters the binding of [3H]GBR 12935 to dopamine transporter in rat brain regions and spinal cord. (1996) (4)
- Abstinence from U-50,488H, a kappa-opiate receptor agonist, decreases the binding of [3H]DAPT to 5-HT1A receptors in the hypothalamus of the rat (1992) (4)
- Selective inhibition of the binding of 3H-(3-MeHis2)thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids (1988) (4)
- The binding of 3H-quinuclidinyl benzilate to cholinergic muscarinic receptors in rat brain region following chronic treatment with morphine and during abstinence (1984) (4)
- The effects of divalent ions on morphine analgesia and abstinence syndrome in morphine-tolerant and-dependent mice (1978) (4)
- A pharmacokinetic analysis of the vagal release of 5-hydroxytryptamine in the cat (2005) (4)
- Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice. (1988) (4)
- Effect of melanotropin release inhibiting factor on changes by haloperidol and centbutindole in cerebral cortical 5-hydroxytryptamine receptors. (1990) (4)
- Cardiovascular responses to pentazocine and tripelennamine in anesthetized rats. (1980) (4)
- Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist. (1989) (4)
- Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats. (1988) (4)
- Cyclo(Leu-Gly): a possible treatment for tardive dyskinesia? (1983) (4)
- Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors (1986) (3)
- Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice (1993) (3)
- The effects of splanchnic nerve stimulation on the plasma levels of serotonin and substance P in the portal vein of the cat (2005) (3)
- Opiate antagonist binding sites in discrete brain regions of spontaneously hypertensive and normotensive Wistar-Kyoto rats. (1991) (3)
- Interaction of TRH and Opiates at the Level of Their Respective Brain Receptors a (1989) (3)
- Detection of beta-endorphin in human blood. A study of performance characteristics of different radiometric systems. (1992) (3)
- Up-regulation of Brain N-Methyl-D-aspartate Receptors Following Multiple Intracerebro- ventricular Injections of [D-Pen2, D-Pen5] Enkephalin and [D-Ala2, Glu4]deltorphin II in Mice (1997) (3)
- Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding. (1997) (3)
- Effects of Some 7-Arylidene and 7-Heteroarylidene Morphinan-6-ones on the Antinociceptive Activity of [d-Pen2, d-Pen5];enkephalin and [d-Ala2, Glu4]deltorphin II and on Multiple Opioid Receptors (1997) (3)
- Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice. (1993) (3)
- Molecular mechanisms of ligand binding to opioid receptors: selective inhibition by ethanol? (1986) (3)
- Lack of interaction between thyrotropin releasing hormone and its analogs with 3H-quinuclidinyl benzilate recognition sites in the rat striatum (1985) (2)
- Enhanced sensitivity to pentobarbital in haloperidol or pimozide treated mice and rats. (1980) (2)
- Alteration of narcotic effects by calcium and other ions (1974) (2)
- Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on morphine-induced antinociception and brain mu, delta and kappa opiate receptors. (1983) (2)
- Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes. (1991) (2)
- Effect of low pH treatment on opioid peptides binding to their receptors and functional coupling of G-proteins to adenylyl cyclase in the rat spinal cord (1996) (2)
- Down-regulation of brain and spinal cord K-opiate receptors in spontaneously hypertensive, Wistar-Kyoto normotensive, and Sprague-Dawley rats by chronic treatment with U-50, 488H. (1991) (2)
- Spinal cord thyrotropin releasing hormone receptors of morphine tolerant-dependent and abstinent rats (1990) (2)
- Interactions of Cocaine with Morphine, U-50,488H and [d-Pen2, d-Pen5]Enkephalin (1998) (2)
- Evidence for the role of nitric oxide in kappa-opiate tolerance in mice. (1993) (2)
- Subsensitivity to noradrenaline and isoprenaline in rabbits acutely pre-treated with morphine. (1977) (2)
- Effect of acute and chronic morphine administration on brain cholinergic muscarinic receptors. (1986) (2)
- The binding of 3H-DAMGO to discrete brain regions and spinal cord of spontaneously hypertensive (SHR) and wistar-kyoto (WKY) normotensive rats (1990) (1)
- Central TRH Receptors in Genetic Hypertension a (1989) (1)
- The effects of stereoisomers of 2-amino-6(7)- and 9-amino-6-trifluoromethylbenzonorbornenes on food intake, brain serotonin concentration, and monoamine oxidase activity. (1984) (1)
- Absolute Configuration of the Enantiomers of 7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline (Chloroquine). (1988) (1)
- Pharmacological evaluation of 2-amino-6(7)- and 9-amino-6-trifluoromethylbenzonorbornenes, the conformationally rigid analogues of norfenfluramine in mice. (1993) (1)
- Synthesis and Opiate Receptor Binding Properties of 17-Methyl-6,7-dehydro-3,14-dihydroxy-4,5α-epoxy-6,7:4′,5′-pyrimidi nomorphinans. (2000) (1)
- Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat (1992) (1)
- The effects of thyrotropin releasing hormone on pentobarbital tolerance. (1981) (1)
- Effect of trans-3,4-dichloro-N-methyl-N-[2-(1 -pyrrolidin) cyclohexyl]-benzeneacetamide (U-50,488H), a kappa opioid receptor agonist, on intake of food in food-deprived and non-deprived spontaneously hypertensive and normotensive Wistar-Kyoto rats (1989) (1)
- Modification of pharmacological and toxicological effects of acetophenazine, chlorpromazine and thloridazine in morphine-dependent mice. (1979) (1)
- Effect of panax ginseng extract on the pharmacological actions of morphine in the rat. (1990) (1)
- Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit (1984) (1)
- Antagonism of kappa opioid mediated effects in the rat by cyclo (Leu-Gly). (1990) (1)
- Comparative effects of thyrotropin releasing hormone, MK-771 and DN-1417 on morphine abstinence syndrome (2004) (1)
- Structure activity relationship studies with hypothalamic peptide hormones—III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat (1982) (1)
- Enhancement of a κ-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan (1994) (1)
- Neural control of serotonin release from duodenal enterochromaffin cells of the cat. (1978) (1)
- FURTHER EVIDENCE FOR A ROLE OF METABOLITES IN THE PHARMACOLOGICAL ACTION OF MORPHINE IN THE RAT: A MICRODIALYSIS STUDY (1995) (0)
- Contents, Vol. 45, 1992 (1992) (0)
- The effects of centrally acting peptides on the chronic actions of buprenorphine in the rat. (1982) (0)
- Opioid Systems: Cytokines and Immunity (1998) (0)
- Contents, Vol. 37, 1988 (1988) (0)
- Effect of cyclo(Leu-Gly) on reserpine-induced hypomotility and increases in cortical β-adrenergic receptors (2004) (0)
- Brain receptors for thyrotropin releasing hormone in morphine tolerant-dependent rats (1986) (0)
- Effect of mianserine on brain serotonin turnover in mice. (1977) (0)
- Effect of chronic administration of morphine and its withdrawal on the rat brain and spinal cord dopamine D1 receptors. (1990) (0)
- THE EFFECTS OF MELANOCYTE-STIMULATING HORMONE RELEASE INHIBITING FACTOR AND SYNTHETIC ANALOGS ON TOLERANCE TO AND PHYSICAL DEPENDENCE ON MORPHINE (1980) (0)
- Peptides as drugs in the treatment of opiate addiction. (1986) (0)
- BINDING OF [3H]MK-801 TO BRAIN REGIONS AND SPINAL CORD MEMBRANES OF MORPHINE TREATED RATS (1995) (0)
- Subject Index, Vol. 37, 1988 (1988) (0)
- Subject Index, Vol. 47, 1993 (1993) (0)
- Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of delta 1- and delta 2-opioid receptor agonists. (1996) (0)
- 911 – STUDIES WITH NATURALLY OCCURRING CANNABINOIDS AND METABOLITES ON MORPHINE DEPENDENCE (1978) (0)
- Dissociation of tolerance to the analgesic and hypothermic effects of morphine by using thyrotropin releasing hormone H.N. Bhargava, Life Sci., 29 (1981) 1015–1020 (1982) (0)
- Multiple opiate receptors in the brain of spontaneously hypertensive rats (1986) (0)
- TRH Inhibits the Development of Tolerance to and Dependence on Morphine a (1989) (0)
- Thyrotropin releasing hormone trh receptors of the central nervous system of morphine tolerant dependent and abstinent rats (1990) (0)
- Subject Index, Vol. 55, 1997 (1997) (0)
- Enhancement of a kappa-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan. (1994) (0)
- Striatal dopamine receptor function in morphine-tolerant dependent rats: influence of hypothalamic peptides. (1984) (0)
- DIFFERENTIAL EFFECTS OF THYROLIBERIN ON TOLERANCE TO THE ANALGESIC AND HYPOTHERMIC EFFECTS OF MORPHINE IN MICE (1981) (0)
- Subject Index, Vol. 45, 1992 (1992) (0)
- Synthesis of 2′‐Amino‐17‐cyclopropylmethyl‐6,7‐dehydro‐3,14‐dihydroxy‐4,5α‐epox y‐6,7:4′,5′‐thiazolomorphinan from Naltrexone. (1998) (0)
- Effect of cannabinoids on the binding of /sup 3/H-(3-MeHis/sup 2/)TRH to rat brain membranes (1986) (0)
- Contents, Vol. 47, 1993 (2004) (0)
- The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of hyperthyroid rats. (1989) (0)
- Brain Peptides, Neuroleptic-Induced Tolerance, and Dopamine Receptor Supersensitivity (1986) (0)
- Contents, Vol. 55, 1997 (1997) (0)
- Time course of the distribution of morphine in brain regions and spinal cord of shr and wky rats following iv injection (1992) (0)
- Modulation of Immune Function by δ-Opioid Receptor Agonists (1995) (0)
- Effect of repeated administration of U-50,488H on the binding of 3H-SCH 23390 and 3H-spiperone to rat brain and spinal cord dopamine receptors. (1990) (0)
- Peptides as drugs in the treatment of opiate addiction.: (474852004-001) (1986) (0)
- INHIBITION OF TOLERANCE TO HUMAN BETA ENDORPHIN BY A LINEAR AND A CYCLIC PEPTIDE (1981) (0)
- Synthesis and Stereochemical Assignment of 7‐Arylidene and 7‐ Heteroarylidene Morphinan‐6‐ones. (1996) (0)
- Relationship between TRH-induced changes in body temperature and brain TRH receptors in five strains of mice (1986) (0)
- Antagonism of kappa opioid mediated effects in the rat by cyclo(Leu-Gly). (1989) (0)
- The effect of morphine tolerance-dependence and abstinence on mu, delta, and kappa opiate receptors of discrete brain regions and spinal cord of the rat. (1990) (0)
- Molecular Modification of Anticholinergics as Probes for Muscarinic Receptors. Part 3. Conformationally Restricted Analogues of Benactyzine. (1987) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hemendra N. Bhargava?
Hemendra N. Bhargava is affiliated with the following schools:
